EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mapping Trofinetide Polypharmacology in Rett Syndrome: A Multi‐Stage Computational Analysis

Luis Felipe Hernández-Ayala iD, Gabriel Eduardo Guzmán-López iD, Annia Galano iD

Journal of Computational Chemistry · 05.08.2026 · 47 (21)

DOI: 10.1002/jcc.70468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Computational Chemistry, online erschienen am 30.07.2026. Verfasst von Luis Felipe Hernández-Ayala und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química, Universidad Autónoma Metropolitana Unidad Iztapalapa, Mexico City, Mexico. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Rett Syndrome. Die Arbeit nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SECIHTI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rett syndrome (RTT) is a severe neurodevelopmental disorder caused by mutations in the MECP2 gene. Although trofinetide is the first FDA‐approved drug for RTT, its pharmacological mechanism remains unclear. We present a structure‐based in silico workflow that integrates target prediction, molecular docking, and 100 ns molecular dynamics (MD) simulations to prioritize potential RTT‐relevant targets. Candidate receptors were ranked using a comparative pleiotropic score ( P S ), as well as an interaction similarity index ( S SI ) relative to endogenous substrates and reference modulators. Five targets emerged as high‐priority candidates (GAT1, GABA A , CHRM1, AMPA, and GSK3β) and were further examined using MD. The simulations supported several binding hypotheses: (i) stable occupation of the orthosteric site in GAT1 and CHRM1, with persistent contacts with ligand‐recognition‐associated residues (Tyr60 in GAT1 and Asp105 in CHRM1); (ii) sustained binding within the catalytic cleft of GSK3β with recurrent interactions near key catalytic elements (including Lys85); and (iii) dynamic, surface‐associated binding modes in GABA A and AMPA, with peripheral residues. In different targets, the proline fragment frequently contributes to hydrophobic anchoring. Taken together, these results provide testable structural hypotheses for the multi‐target interaction of trofinetide in RTT and a computational framework to guide experimental validation and next‐generation multi‐target design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Dynamics SimulationRett SyndromeHumansMolecular Docking SimulationReceptors, GABA-A

Stichwörter der Autor:innen

Rett syndromemolecular dockingmolecular dynamicstrofinetide

Substanzen

Receptors, GABA-A

Autor:innen und Institutionen

  • Departamento de Química, Universidad Autónoma Metropolitana Unidad Iztapalapa, Mexico City, Mexico.

ORCID-Profile: Luis Felipe Hernández-Ayala, Gabriel Eduardo Guzmán-López, Annia Galano

Förderung

  • SECIHTI

Zitieren

APA

Hernández-Ayala, L. F., Guzmán-López, G. E., & Galano, A. (2026). Mapping Trofinetide Polypharmacology in Rett Syndrome: A Multi‐Stage Computational Analysis. Journal of Computational Chemistry, 47(21). https://doi.org/10.1002/jcc.70468

Vancouver

Hernández-Ayala LF, Guzmán-López GE, Galano A. Mapping Trofinetide Polypharmacology in Rett Syndrome: A Multi‐Stage Computational Analysis. Journal of Computational Chemistry. 2026;47(21). doi:10.1002/jcc.70468

BibTeX
@article{HernndezAyala2026,
  author = {Hernández-Ayala, Luis Felipe and Guzmán-López, Gabriel Eduardo and Galano, Annia},
  title = {Mapping Trofinetide Polypharmacology in Rett Syndrome: A Multi‐Stage Computational Analysis},
  journal = {Journal of Computational Chemistry},
  year = {2026},
  volume = {47},
  number = {21},
  doi = {10.1002/jcc.70468}
}
Kostenlos starten →